Video AMP 2023
Value of Alternative Access for Treatment of Multilevel and Multivessel Disease
Fadi A. Saab, MD, FASE, FACC, FSCAI
Advanced Cardiac and Vascular Centers, Grand Rapids, Michigan
06/28/2023
In this case, the common nature of CLTI patients with multivessel, multilevel disease and multiple comorbidities is well demonstrated. The use of strategies to reduce contrast and radiation exposure for these patients is very important for success of revascularization. This case highlights the use of these technologies and the importance of staging patients with complex CLI disease.
Join us at the 2023 Amputation Prevention Symposium (AMP), taking place August 16-19 in Chicago, to see similar complex cases performed live by expert operators.
